Coeptis Therapeutics Holdings, Inc. financial data

Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
105 Bradford Road, Suite 420, Wexford, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Bull Horn Holdings Corp. (to 10/28/2022)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 36.4 % -58.8%
Debt-to-equity 289 % -5.37%
Return On Equity -588 % +61.9%
Return On Assets -168 % +56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.36M shares -90.7%
Common Stock, Shares, Outstanding 2.12M shares +19.8%
Entity Public Float 8.46M USD -70.6%
Common Stock, Value, Issued 212 USD +18.4%
Weighted Average Number of Shares Outstanding, Basic 1.92M shares +49.8%
Weighted Average Number of Shares Outstanding, Diluted 1.92M shares +49.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 2.33M USD -65%
Selling and Marketing Expense 0 USD -100%
General and Administrative Expense 946K USD -7.87%
Operating Income (Loss) -10.1M USD +53.2%
Nonoperating Income (Expense) -823K USD -466%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.9M USD +48.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.9M USD +48.9%
Earnings Per Share, Basic -5.65 USD/shares +65.9%
Earnings Per Share, Diluted -5.65 USD/shares +65.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 1.05M USD -39.9%
Property, Plant and Equipment, Net 10.5K USD -7.48%
Operating Lease, Right-of-Use Asset 59.8K USD -38.7%
Assets 8.91M USD +94.9%
Accounts Payable, Current 1.27M USD -10.6%
Accrued Liabilities, Current 737K USD +32.5%
Liabilities, Current 4.51M USD +51%
Operating Lease, Liability, Noncurrent 18.9K USD -69.1%
Liabilities 5.04M USD +34.2%
Retained Earnings (Accumulated Deficit) -98.2M USD -12.5%
Stockholders' Equity Attributable to Parent 3.19M USD +291%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.87M USD +375%
Liabilities and Equity 8.91M USD +94.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 40M shares +21.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 533K USD -63.7%
Deferred Tax Assets, Valuation Allowance 25.6M USD +10.6%
Deferred Tax Assets, Gross 25.6M USD +10.6%
Operating Lease, Liability 61.2K USD -38.3%
Lessee, Operating Lease, Liability, to be Paid 65.4K USD -42.9%
Property, Plant and Equipment, Gross 25.2K USD 0%
Operating Lease, Liability, Current 42.3K USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.3K USD -58.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 46.1K USD +1.58%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.22K USD -72.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.3K USD
Deferred Tax Assets, Operating Loss Carryforwards 25M USD +11.1%
Preferred Stock, Shares Issued 5.83K shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 103M USD +12.3%
Preferred Stock, Shares Outstanding 5.83K shares
Interest Expense 300K USD +73.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%